+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

How phase III therapeutic trials in multiple sclerosis should be evaluated: advances and challenges

How phase III therapeutic trials in multiple sclerosis should be evaluated: advances and challenges

Revue Neurologique 155(Suppl. 2): S7-12

Please choose payment method:

(PDF emailed within 1 workday: $29.90)

Accession: 046280722

Download citation: RISBibTeXText

PMID: 10367319

Related references

How should phase III therapeutic trials in multiple sclerosis be evaluated Advances and challenges. Revue Neurologique (Paris) 155(Suppl. 2): 2S7-2S12, 1999

Therapeutic Advances and Challenges in the Treatment of Progressive Multiple Sclerosis. Drugs 78(15): 1549-1566, 2018

Guidelines for clinical trials of new therapeutic agents in multiple sclerosis Reporting extended results from phase III clinical trials. Annals of Neurology 46(1): 132-134, 1999

The natural history of multiple sclerosis: a geographically based study. 6. Applications to planning and interpretation of clinical therapeutic trials in primary progressive multiple sclerosis. Brain 122: 641-647, 1999

The future of multiple sclerosis therapies: redesigning multiple sclerosis clinical trials in a new therapeutic era. Multiple Sclerosis 11(6): 669-676, 2005

Specific power calculations for magnetic resonance imaging (MRI) in monitoring active relapsing-remitting multiple sclerosis (MS): implications for phase II therapeutic trials. Multiple Sclerosis 2(6): 283-290, 1997

Expanded clinical trials of treatments for multiple sclerosis. The Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis of The National Multiple Sclerosis Society. Annals of Neurology 34(6): 755-756, 1993

Multiple sclerosis clinical trials: old and new challenges. Seminars in Neurology 18(3): 377-388, 1998

Imaging Pediatric Multiple Sclerosis-Challenges and Recent Advances. Neuropediatrics 49(3): 165-172, 2018

Recent advances and future challenges in the genetics of multiple sclerosis. Frontiers in Neurology 5: 130, 2014

Multiple Sclerosis: A Global Concern with Multiple Challenges in an Era of Advanced Therapeutic Complex Molecules and Biological Medicines. Biomedicines 6(4):, 2018

Amyotrophic lateral sclerosis. Recent advances in pathogenesis and therapeutic trials. Archives of Neurology 45(2): 189-202, 1988

Therapeutic advances in pediatric multiple sclerosis. Journal of Pediatrics 163(3): 631-637, 2013

Clinical trials in pediatric multiple sclerosis: overcoming the challenges. Clinical Investigation 3(1): 49-56, 2013

Ethical challenges in paediatric clinical trials in multiple sclerosis. Therapeutic Advances in Neurological Disorders 5(3): 139-146, 2012